Libo Pharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	3,246	3,702	-	-
Enterprise Value	2,447	3,366	-	-
Last Close Price	43.15	49.20	-	-
PB Ratio	3.06	3.49	-	-
P/TBV Ratio	3.56	4.06	-	-
Debt / Equity Ratio	0.00	0.00	0.01	0.04
Net Debt / Equity Ratio	-0.75	-0.75	-0.59	-0.81
Net Debt / EBITDA Ratio	2.79	2.79	2.02	1.60
Net Debt / FCF Ratio	2.29	2.29	2.27	2.00
Quick Ratio	37.40	37.40	33.63	8.83
Current Ratio	43.19	43.19	35.39	9.12
Return on Equity (ROE)	-39.01%	-39.01%	-54.02%	-
Return on Assets (ROA)	-24.86%	-24.86%	-33.29%	-
Return on Capital Employed (ROCE)	-29.10%	-29.10%	-32.90%	-53.70%
Earnings Yield	-9.13%	-8.00%	-	-
FCF Yield	-10.77%	-9.45%	-	-
Buyback Yield / Dilution	-33.57%	-33.57%	-76.69%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.